Zdrowie i gospodarka · 01/02/2019

FDA Announces Draft Guidance for Industry on Survey Methodologies for Assessing Risk Evaluation and Mitigation Strategies

The FDA has released a draft guidance document outlining recommendations for industry on conducting surveys to evaluate patients' and healthcare providers' knowledge of REMS-related information, with the goal of assessing risk evaluation and mitigation strategies.